- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, February 21, 2020
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A press release from MDVIP posted on Yahoo Finance cited a study published in the December 2012 issue of The American Journal of Managed Care® (AJMC®). The study, titled “Personalized Preventive Care Leads to Significant Reductions in Hospital Utilization,” found that Medicare patients in MDVIP-affiliated practices were admitted to the hospital 79% less than patients in traditional practices and commercial patients were in the hospital 72% less.
A piece by McKnight's Senior Living discussing telemedicine benefits for senior living and care referenced an April 2016 contributor article published on AJMC.com. The article, “Telemedicine: A Game Changer for Senior Healthcare,” highlighted that reducing transportation costs for in-person physician office visits can save long-term care facilities $479 million each year.
Nurse.com’s article on the link between illegal fentanyl and opioid-related deaths spotlighted a March 2019 article published on AJMC.com, “Drops in First-Time Opioid Prescriptions Highlight Progress, but Also Some Concern.” Researchers of the study found that a significant proportion of providers stopped prescribing opioids; but while overall incidence dropped, a subgroup of providers continued to prescribe high-risk doses of opioids, and for long durations.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
